Mohan Mishra (19 May 1937 - 6 May 2021)[1] was an Indian physician, known for his studies on Visceral leishmaniasis, (Kala Azar) and its treatment using Amphotericin B, regarded by many as a pioneering attempt.
Another higher degree of FRCP was obtained in 1984 from Edinburgh and two years later, in 1986, he became the Head of the Department of General Medicine at the DMCH.
[2] Leishmaniasis, the second largest parasitic killer after Malaria[6] and known locally as Kala Azar, was a common disease in the area and, after extensive research[3] funded by the World Health Organization, Dr. Mishra proposed the use of Amphotericin B (Fungizone) to combat the disease through an article he published in Lancet in 1991.
His studies on the subject, assisted by his son, Narottam Mishra[7] who is an information scientist at the Kameshwar Singh Darbhanga Sanskrit University, have been successful in finding a cost-effective way to eliminate arsenic from drinking water by using food-grade alum.
[3][4] He has shown that Brahmi (Bacopa monnieri), a herb traditionally used in India, can be effective in the treatment of Dementias.